ASC ICD Reg: Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
Sponsor
QuesGen Systems Inc (Other)
Overall Status
Recruiting
CT.gov ID
NCT03604133
Collaborator
Cardio Surgical Partners (Other)
500
1
132
3.8
Study Details
Study Description
Brief Summary
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
500 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
Actual Study Start Date
:
Aug 24, 2017
Anticipated Primary Completion Date
:
Aug 24, 2023
Anticipated Study Completion Date
:
Aug 24, 2028
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients receiving ICD devices
|
Outcome Measures
Primary Outcome Measures
- Successful Implantation [Two-week follow-up assessment]
Patient undergoes surgery for ICD device implantation
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)
Exclusion Criteria:
- N/A
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cardio Surgical Partners, LLC | Lehi | Utah | United States | 84043 |
Sponsors and Collaborators
- QuesGen Systems Inc
- Cardio Surgical Partners
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
QuesGen Systems Inc
ClinicalTrials.gov Identifier:
NCT03604133
Other Study ID Numbers:
- 2018-310 Cardiac Registry
First Posted:
Jul 27, 2018
Last Update Posted:
Jan 22, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: